Compare HSBC Holdings plc (HSBC) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Tempus AI — how do they compare? HSBC Holdings plc trades at $92.99 (market cap $319.39B), while Tempus AI trades at $69.95 (market cap $12.77B). The key difference: HSBC Holdings plc is far larger — about 25× Tempus AI's market cap, and HSBC Holdings plc pays a 4% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold HSBC Holdings plc for 36 Days and Tempus AI for 22 Days on average.
| HSBC | TEM | |
|---|---|---|
Market Cap | $319.39B | $12.77B |
Volume | 2,543,839 | 8,980,490 |
Sector | Financials | Broad Market / Factor |
52-Week High | $107.86 | $99.28 |
52-Week Low | $65.67 | $41.55 |
Typical Hold Time | 36 Days | 22 Days |
Enterprise Value | $216.95B | $13.40B |
Dividend Yield | 4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $93.71, down 3.97% today, with bearish technical signals dominating. The stock shows solid fundamentals with a P/E of 13.39 and net income margin of 34.54%, while recent earnings show mixed results with two beats and one miss. Recent corporate developments include expansion in technology banking and wealth management services, alongside strategic exits from lower-growth markets like Germany.
The outlook remains cautiously optimistic given strong profitability metrics and strategic growth initiatives, though near-term technical weakness and CFO transition risks warrant monitoring. Analyst consensus leans neutral with 52.38% hold ratings, reflecting balanced views on HSBC's Asia-focused growth strategy versus execution challenges.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
